Allied Market Research
Loading...
0
New
New
2022
Vascular Disease Devices Market

Vascular Disease Devices Market by Product (Stents, Balloons, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), and End User (Hospitals and Cardiac Centers, and Ambulatory Surgical Center): Global Opportunity Analysis and Industry Forecast, 2021––2030

A15582
Pages: 220
Jan 2022 | 684 Views
   
Author(s) : Prathmesh Bhasme Vishal Bhardwaj , Onkar Sumant
Tables: 180
Charts: 62
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vascular Disease Devices Market

Request Now !

Vascular Disease Devices Market Statistics - 2030

The global vascular disease devices market was valued at $26,522.24 million in 2020, and is projected to reach $ 51,802.14 million by 2030, registering a CAGR of 6.50% from 2021 to 2030. Vascular diseases are conditions that affect natural blood circulatory system of the body. Vascular diseases include peripheral artery disease (PAD). The vascular diseases include stroke, peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), critical limb-threatening ischemia (CLTI), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. High blood pressure, cholesterol deposition, vascular injury, genetic, and infections can affect the natural circulatory systems. In addition, obesity, diabetes, alcohol consumption, and tobacco smoking increase the risk of vascular diseases.

The impact of COVID-19 pandemic is expected to remain negative for the global vascular disease devices market. The companies are facing a setback, owing to the lock-down, which led to a drop in the manufacturing and the patient flow reduced substantially. In addition, wave of COVID-19 has create burden on hospitals, resulting in cancellation or delayed vascular surgeries. However, the advancements in vascular devices and improved healthcare infrastructure will boost the growth of the vascular disease devices market post-pandemic.

The specially designed devices such as vascular stents, balloons, and catheters, are used to treat vascular malfunction or plaque from veins to restore the natural blood flow. Stents are often used to treat narrowed coronary arteries that supply the heart with oxygen-rich blood. The stent holds open the narrowed arteries to allow adequate blood to flow to the heart. In balloon angioplasty, a balloon is attached to a catheter that's inserted into an artery and at the place where deposits of plaque have closed off or narrowed the channel for blood flow, the balloon is inflated.

Vasculator Disease Devices Market, 2021-2030

Get more information on this report : Request Sample Pages

The growth of the global vascular disease devices market is majorly driven by an increase in vascular diseases, such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders as well as increase in number of hospitals and surgery centers boost the diagnosis and treatment of diseases. For instance, according to the report of the American Heart Association, in 2019, 197.2 million people were living with ischemic heart disease (IHD). In addition, an increase in cardiovascular disorders is one of the key drivers of the market. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019.

Moreover, advancement in vascular disease devices is anticipated to contribute toward the growth of the market. For instance, Becton, Dickinson, and Company (BD), a leading supplier of innovative medical devices, received approval from the U.S. FDA in 2019, for the ‘Venovo’ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which has obstructed or narrowed blood flow specific to the iliac and femoral veins located near the groin. However, product failure and product recalls restricted the market growth during the forecast period.

global vascular disease devices market segmentation

The vascular disease devices market is segmented on the basis of product, end-user, and region. By product, the market is mainly categorized into stents, balloons, catheters, plaque modification devices, hemodynamic flow alteration devices, and others.

The stents are further divided into coronary stents, peripheral stents, and stents-related products. The coronary stents are divided into drug-eluting stents, bare-metal coronary stents, and bioabsorbable stents.

The peripheral stents are further classified as iliac, femoral-popliteal, renal, and carotid. The stent-related products are classified as synthetic grafts and vena cava filters. The balloons are further classified into bare/normal balloons, drug-coated balloons, and scoring balloons. The catheters are classified as angiography, IVUS/OCT, and guiding. Depending on end-user, it is categorized into hospitals & cardiac centers and ambulatory surgical centers.

Vascular Disease Devices Market
By Product

Your browser does not support the canvas element.

Stents segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).

Segment Review

Depending on product, the stents segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in cardiovascular diseases. However, the balloons segment is expected to witness considerable growth during the forecast period, owing to rise in the geriatric population.

Vascular Disease Devices Market
By End User

Your browser does not support the canvas element.

Hospital & cardiac centers segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Depending on end-user, the hospitals & cardiac centers segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to an increase in the number of hospitals and surgery centers. However, the ambulatory surgical center segment is expected to witness considerable growth during the forecast period, due to the cost effectiveness of ambulatory surgical centers.

North America garnered the major share in the vascular disease devices market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of chronic diseases, presence of key players for manufacturing & development of vascular disease devices, increase in the number of hospitals & diagnostic centers and initiatives taken by government for the treatment of vascular diseases in the region. However, Asia-Pacific is expected to register the highest CAGR of 7.30% from 2021 to 2030, owing to an increase in the number of vascular surgeries, and a high population.

The key players operating in the global vascular disease devices market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, Cordis, B. Braun Melsungen Ag, Ivascular, Merit Medical, and Koninklijke Philips N.V.

Vascular Disease Devices Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The report provides an in-depth analysis of the global vascular disease devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular disease devices market growth.

Key Market Segments

  • BY PRODUCT
    • Stents
      • Coronary Stents
      • Peripheral Stents
      • Stent Related Implant
    • Balloons
      • Bare/Normal balloons
      • Drug coated balloons
      • Scoring balloons
    • Catheters
      • Angiography
      • IVUS/OCT
      • Guiding
    • Plaque Modification Devices
    • Hemodynamic Flow Alteration Devices
    • Others
  • BY END USER
    • Hospitals & cardiac centers
    • Ambulatory Surgical Center
  • BY REGION
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Koninklijke Philips N.V. (Philips)
  • Medtronic Plc.
  • Abbott Laboratories.
  • Boston scientific corporation.
  • Becton Dickinson And Company.
  • Terumo Corporation.
  • Cordis
  • BRAUN MELSUNGEN AG
  • IVASCULAR
  • Merit Medical Systems, Inc.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of cardiovascular diseases
3.5.1.2.Rise in number of diabetes and hypertension patients
3.5.1.3.The R&D in vascular disease

3.5.2.Restraint

3.5.2.1.Product recall and failure

3.5.3.Opportunity

3.5.3.1.Increase in aging population.

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the vascular disease devices market

CHAPTER 4:VASCULAR DISEASES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Stents

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis by country
4.2.4.Market size and forecast, by stents types

4.2.4.1.Coronary Stents
4.2.4.2.Peripheral Stents
4.2.4.3.Stent Related Implant

1.2Balloons

4.2.5.Key market trends, growth factors, and opportunities
4.2.6.Market size and forecast, by region
4.2.7.Market analysis by country

4.2.7.1.Bare/Normal balloons
4.2.7.2.Drug coated balloons
4.2.7.3.Scoring balloons

1.3Catheters

4.2.8.Key market trends, growth factors, and opportunities
4.2.9.Market size and forecast, by region

4.2.10.Market analysis by country

4.2.10.1.Angiography
4.2.10.2.IVUS/OCT
4.2.10.3.Guiding

1.4Plaque Modification Devices

4.2.11.Key market trends, growth factors, and opportunities

4.2.12.Market size and forecast, by region
4.2.13.Market analysis by country

1.5Hemodynamic Flow Alteration Devices

4.2.14.Key market trends, growth factors, and opportunities
4.2.15.Market size and forecast, by region
4.2.16.Market analysis by country

1.6Others

4.2.17.Key market trends, growth factors, and opportunities
4.2.18.Market size and forecast, by region
4.2.19.Market analysis by country

CHAPTER 5:VASCULAR DISEASE DEVICES MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals & cardiac centers

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Ambulatory Surgical Center

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

CHAPTER 6:VASCULAR DISEASE DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. vascular disease devices market, by product
6.2.2.1.2.U.S. vascular disease devices market, by end user

6.2.2.2.Canada

6.2.2.2.1.Canada vascular disease  devices market, by product
6.2.2.2.2.Canada vascular disease devices market, by end user

6.2.2.3.Mexico

6.2.2.3.1.Mexico vascular disease devices market, by product
6.2.2.3.2.Mexico vascular disease devices market, by end user

6.2.3.North America vascular disease devices market, by product
6.2.4.North America vascular disease devices market, by end user

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany vascular disease devices market, by product
6.3.2.1.2.Germany vascular disease devices market, by end user

6.3.2.2.France

6.3.2.2.1.France vascular disease devices market, by product
6.3.2.2.2.France vascular disease devices market, by end user

6.3.2.3.UK

6.3.2.3.1.UK vascular disease devices market, by product
6.3.2.3.2.UK vascular disease devices market, by end user

6.3.2.4.Italy

6.3.2.4.1.Italy vascular disease devices market, by product
6.3.2.4.2.Italy vascular disease devices market, by end user

6.3.2.5.Spain

6.3.2.5.1.Spain vascular disease devices market, by product
6.3.2.5.2.Spain vascular disease devices market, by end user

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe vascular disease devices market, by product
6.3.2.6.2.Rest of Europe vascular disease devices market, by end user

6.3.3.Europe vascular disease devices market, by product
6.3.4.Europe vascular disease devices market, by end user

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.China

6.4.2.1.1.China vascular disease devices market, by product
6.4.2.1.2.China vascular disease devices market, by end user

6.4.2.2.Japan

6.4.2.2.1.Japan vascular disease devices market, by product
6.4.2.2.2.Japan vascular disease devices market, by end user

6.4.2.3.India

6.4.2.3.1.India vascular disease devices market, by product
6.4.2.3.2.India vascular disease devices market, by end user

6.4.2.4.Australia

6.4.2.4.1.Australia vascular disease devices market, by product
6.4.2.4.2.Australia vascular disease devices market, by end user

6.4.2.5.South Korea

6.4.2.5.1.South Korea vascular disease devices market, by product
6.4.2.5.2.South Korea vascular disease devices market, by end user

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific vascular disease devices market, by product
6.4.2.6.2.Rest of Asia-Pacific vascular disease devices market, by end user

6.4.3.Asia-Pacific vascular disease devices market, by product
6.4.4.Asia-Pacific vascular disease devices market, by end user

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil vascular disease devices market, by product
6.5.2.1.2.Brazil vascular disease devices market, by end user

6.5.2.2.Saudi Arabia

6.5.2.2.1.Saudi Arabia vascular disease devices market, by product
6.5.2.2.2.Saudi Arabia vascular disease devices market, by end user

6.5.2.3.South Africa

6.5.2.3.1.South Africa vascular disease devices market, by product
6.5.2.3.2.South Africa vascular disease devices market, by end user

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA vascular disease devices market, by product
6.5.2.4.2.Rest of LAMEA vascular disease devices market, by end user

6.5.3.LAMEA vascular disease devices market, by product
6.5.4.LAMEA vascular disease devices market, by end user

CHAPTER 7:COMPANY PROFILES

7.1.Koninklijke Philips N.V. (Philips)

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance

7.2.Medtronic Plc.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segment
7.2.4.Product portfolio
7.2.5.Business performance

7.3.Abbott Laboratories.

7.3.1.Company overview
7.3.2.Operating business segment
7.3.3.Product portfolio
7.3.4.Business performance
7.3.5.Key strategic moves and developments

7.4.Boston scientific corporation.

7.4.1.Company overview
7.4.2.Operating business segment
7.4.3.Product portfolio
7.4.4.Business performance
7.4.5.Key strategic moves and developments

7.5.Becton Dickinson And Company.

7.5.1.Company overview
7.5.2.Operating business segment
7.5.3.Product portfolio
7.5.4.Business performance

7.6.Terumo Corporation.

7.6.1.Company overview
7.6.2.Operating business segment
7.6.3.Product portfolio
7.6.4.Business performance
7.6.5.Key strategic moves and developments

7.7.Cordis

7.7.1.Company overview
7.7.2.Operating business segment
7.7.3.Product portfolio
7.7.4.Business performance

7.8.B. BRAUN MELSUNGEN AG

7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performance

7.9.IVASCULAR

7.9.1.Company overview
7.9.2.Operating business segment
7.9.3.Product portfolio
7.9.4.Key strategic moves and developments

7.10.Merit Medical Systems, Inc.

7.10.1.Company overview
7.10.2.Operating business segment
7.10.3.Product portfolio
7.10.4.Business performance
7.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.VASCULAR DISEASES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 01.VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.VASCULAR DISEASE DEVICES MARKET FOR BALLOONS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.VASCULAR DISEASE DEVICES MARKET FOR CATHETERS, BY REGION, 2020–2030 ($MILLION)
TABLE 04.VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 05.VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 06.VASCULAR DISEASE DEVICES MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 08.VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.VASCULAR DISEASE DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.VASCULAR DISEASE DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12.U.S. VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 13.U.S. VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14.CANADA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15.CANADA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 16.MEXICO VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17.MEXICO VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20.EUROPE  VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.GERMANY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.GERMANY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23.FRANCE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24.FRANCE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.UK VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.UK VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27.ITALY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.ITALY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29.SPAIN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 30.SPAIN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32.REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.EUROPE VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 34.EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.ASIA-PACIFIC VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36.CHINA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37.CHINA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.JAPAN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39.JAPAN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40.INDIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.INDIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42.AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 43.AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.SOUTH KOREA VASCULAR DISEASES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45.SOUTH KOREA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46.REST OF ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.REST OF ASIA PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 49.ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.LAMEA VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 51.BRAZIL VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 52.BRAZIL VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54.SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 56.SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58.REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59.LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60.LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61.PHILIPS: COMPANY SNAPSHOT
TABLE 62.PHILIPS: OPERATING SEGMENTS
TABLE 63.PHILIPS: PRODUCT PORTFOLIO
TABLE 64.MEDTRONIC: COMPANY SNAPSHOT
TABLE 65.MEDTRONIC: OPERATING SEGMENT
TABLE 66.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 67.ABBOTT: COMPANY SNAPSHOT
TABLE 68.ABBOTT: OPERATING SEGMENT
TABLE 69.ABBOTT: PRODUCT PORTFOLIO
TABLE 70.ABBOTT.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71.BOSTON: COMPANY SNAPSHOT
TABLE 72.BOSTON: OPERATING SEGMENT
TABLE 73.BOSTON: PRODUCT PORTFOLIO
TABLE 74.BOSTON.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75.BD: COMPANY SNAPSHOT
TABLE 76.BD: OPERATING SEGMENT
TABLE 77.BD: PRODUCT PORTFOLIO
TABLE 78.TERUMO: COMPANY SNAPSHOT
TABLE 79.TERUMO: OPERATING SEGMENT
TABLE 80.TERUMO: PRODUCT PORTFOLIO
TABLE 81.TERUMO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82.CORDIS: COMPANY SNAPSHOT
TABLE 83.CORDIS: OPERATING SEGMENT
TABLE 84.CORDIS: PRODUCT PORTFOLIO
TABLE 85.B. BRAUN: COMPANY SNAPSHOT
TABLE 86.B. BRAUN: OPERATING SEGMENT
TABLE 87.B. BRAUN: PRODUCT PORTFOLIO
TABLE 88.IVASCULAR: COMPANY SNAPSHOT
TABLE 89.IVASCULAR: OPERATING SEGMENT
TABLE 90.IVASCULAR: PRODUCT PORTFOLIO
TABLE 91.IVASCULAR.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.MERIT: COMPANY SNAPSHOT
TABLE 93.MERIT: OPERATING SEGMENT
TABLE 94.MERIT: PRODUCT PORTFOLIO
TABLE 95.MERIT.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.VASCULAR DISEASE DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR STENTS BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.VASCULAR DISEASE DEVICES MARKET DRUG-ELUTING STENTS, 2020 & 2030 ($MILLION)
FIGURE 15.VASCULAR DISEASE DEVICES MARKET BARE-METAL CORONARY STENTS, 2020 & 2030 ($MILLION)
FIGURE 16.VASCULAR DISEASE DEVICES MARKET BIOABSORBABLE STENTS, 2020 & 2030 ($MILLION)
FIGURE 17.VASCULAR DISEASE DEVICES MARKET ILIAC ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 18.VASCULAR DISEASE DEVICES MARKET FEMORAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 19.VASCULAR DISEASE DEVICES MARKET RENAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 20.VASCULAR DISEASE DEVICES MARKET CAROTID ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 21.VASCULAR DISEASE DEVICES MARKET SYNTHETIC GRAFTS, 2020 & 2030 ($MILLION)
FIGURE 22.VASCULAR DISEASE DEVICES MARKET VENA CAVA FILTERS, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR BALLOONS BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.BARE/NORMAL BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 25.DRUG-COATED BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 26.SCORING BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR CATHETERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 28.ANGIOGRAPHY IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 29.IVUS / OCT IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 30.GUIDING IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 34.COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2030 (%)
FIGURE 35.COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 36.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 39.MEDTRONIC: NET SALES, 2020 ($MILLION)
FIGURE 40.MEDTRONIC: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 41.MEDTRONIC: REVENUE SHARE BY REGION 2020(%)
FIGURE 42.ABBOTT: NET SALES, 2020 ($MILLION)
FIGURE 43.ABBOTT: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 44.ABBOTT: REVENUE SHARE BY REGION 2020(%)
FIGURE 45.BOSTON: NET SALES, 2020 ($MILLION)
FIGURE 46.BOSTON: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 47.BOSTON: REVENUE SHARE BY REGION 2020(%)
FIGURE 48.BD: NET SALES, 2020 ($MILLION)
FIGURE 49.BD: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 50.BD: REVENUE SHARE BY REGION 2020(%)
FIGURE 51.TERUMO: NET SALES, 2020 ($MILLION)
FIGURE 52.TERUMO: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 53.TERUMO: REVENUE SHARE BY REGION 2020(%)
FIGURE 54.CORDIS: NET SALES, 2020 ($MILLION)
FIGURE 55.CORDIS: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 56.CORDIS: REVENUE SHARE BY REGION 2020(%)
FIGURE 57.B. BRAUN: NET SALES, 2020 ($MILLION)
FIGURE 58.B. BRAUN: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 59.B. BRAUN: REVENUE SHARE BY REGION 2020(%)
FIGURE 60.MERIT: NET SALES, 2020 ($MILLION)
FIGURE 61.MERIT: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 62.MERIT: REVENUE SHARE BY REGION 2020(%)


 
 

Vascular disease is a group of multiple conditions that affect the natural blood circulation system in the body.

The vascular disease devices include stents, balloons, catheters, and vena cava filters. The stents and balloons are inserted into the vessels to restore the natural blood flow. Vena cava filters are used to prevent blood clots from moving from the vein in the legs to the lung, which would result in a life-threatening pulmonary embolism.

The factors such as increase in the prevalence of vascular diseases such as ischemic heart & stroke, the rise in the geriatric population, advancements in vascular disease treatment, and the surge of obesity mainly due to sedentary nature of many forms of work. In addition, an increase in the number of diabetes and hypertension patients is expected to drive the growth of the vascular disease devices market. Moreover, the rise in the number of alcohol consumers and tobacco smokers further boost the growth of the market.

North America is expected to witness the highest growth, in terms of revenue, owing to rise in the prevalence of coronary artery diseases, the presence of key players for manufacturing and developing vascular disease devices, and increase in number of hospitals and surgical centers, in the region.

However, the high cost of surgery and product recalls & failures can hamper the market growth.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of vasculator disease devices market is $26522.24 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of vasculator disease devices market in 2021 was $29466.2 million

A. The base year for the report is 2020.

A. Yes, vascular disease devices companies are profiled in the report

A. The top companies that hold the market share in vasculator disease devices market are Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson And Company, Terumo Corporation, Cordis, B. Braun Melsungen Ag, Ivascular, Merit Medical, Koninklijke Philips N.V.

A. Asia-Pacific is expected to register the highest CAGR of 7.30% from 2021 to 2030, owing to increase in number of hospitals, a rise in the cardiovascular diseases, and high population.

A. The key trends in the vasculator disease devices market are by an increase in the prevalence of vascular diseases, such as plaque, atherosclerosis; rise in number of vascular surgeries; and initiative taken by government organizations to treat vascular diseases.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Vascular Disease Devices Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers